Jump Financial, LLC Cassava Sciences Inc Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$16.64 - $25.32 $1.72 Million - $2.61 Million	103,135 New	103,135 $1.72 Million
Q3 2023 Nov 07, 2023	BUY	$16.64 - $25.32 $1.72 Million - $2.61 Million	103,135 New	103,135 $1.72 Million
Q1 2022 May 12, 2022	SELL	$32.6 - $53.05 $221,712 - $360,793	-6,801 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$36.77 - $90.91 $74,201 - $183,456	-2,018 Reduced 22.88%	6,801 $297,000
Q3 2021 Nov 12, 2021	BUY	$41.79 - $135.3 $368,546 - $1.19 Million	8,819 New	8,819 $547,000
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $455,759 - $5.65 Million	-64,282 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$6.79 - $12.25 $172,717 - $311,603	-25,437 Reduced 28.35%	64,282 $438,000
Q3 2020 Nov 13, 2020	BUY	$2.86 - $11.51 $256,596 - $1.03 Million	89,719 New	89,719 $1.03 Million

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.